Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Intravenous, Dose‐Ascending Study of Sirukumab in Cutaneous or Systemic Lupus ErythematosusJacek C. Szepietowski, Benjamin Hsu, Robert Gordon et al.|Arthritis & Rheumatism|2013Cited by 115